NCT02354027View on ClinicalTrials.gov

The Drug-drug Interaction of SHR3824 and Metformin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

January 31, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

SHR3824 metformin

"Two 500-mg tablets of metformin on Day 1 followed by 25 mg of SHR3824 once daily on Days 4 through 8 followed by two 500-mg tablets of metformin and 25 mg of SHR3824 on Day 8.~Drug: SHR3824 + Metformin"

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT02354027 - The Drug-drug Interaction of SHR3824 and Metformin | Biotech Hunter | Biotech Hunter